Lytica Therapeutics
Lytica Therapeutics
  • Home
  • Team
  • Science
  • News
  • Careers
  • Contact
    • Home
    • Team
    • Science
    • News
    • Careers
    • Contact
  • Home
  • Team
  • Science
  • News
  • Careers
  • Contact

image1363

James LaTorre, CFA

Loren Walensky, MD, PhD

James LaTorre, CFA

Chief Executive Officer

image1364

Rida Mourtada, PhD

Loren Walensky, MD, PhD

James LaTorre, CFA

Chief Scientific Officer

image1365

Loren Walensky, MD, PhD

Loren Walensky, MD, PhD

Loren Walensky, MD, PhD

Scientific Cofounder

image1366

Arianna Finnegan

Warren Dorsch, PhD

Loren Walensky, MD, PhD

Operations Manager

image1367

Warren Dorsch, PhD

Warren Dorsch, PhD

Warren Dorsch, PhD

Principal Scientist, Chemistry

image1368

Daniel Cohen, PhD

Warren Dorsch, PhD

Warren Dorsch, PhD

Senior Scientist, Protein Chemistry

image1369

Lip Nam Loh, PhD

Deepa Talreja, PhD

Deepa Talreja, PhD

Senior Scientist, Microbiology

image1370

Deepa Talreja, PhD

Deepa Talreja, PhD

Deepa Talreja, PhD

Senior Scientist, Microbiology

image1371

Alfred Tamayo, PhD

Deepa Talreja, PhD

Alfred Tamayo, PhD

Senior Scientist, Pharmacology

image1372

Ashley Curtin

Isabelle Hanna

Alfred Tamayo, PhD

Research Associate, Veterinary Medicine

image1373

Isabelle Hanna

Isabelle Hanna

Isabelle Hanna

Research Associate, Biology

Scientific Advisory Board

James Balkovec, PhD

Deborah Hung, MD, PhD

Deborah Hung, MD, PhD

Principal at ChemTract Consulting

Co-inventor of Caspofungin, the first glucan synthase inhibitor (GSi) for the treatment of serious fungal infections

Deborah Hung, MD, PhD

Deborah Hung, MD, PhD

Deborah Hung, MD, PhD

Associate Professor

Microbiology & Immunology

Richard B. Simches Research Center

Harvard Medical School

Joel Freundlich, PhD

Deborah Hung, MD, PhD

Joel Freundlich, PhD

Associate Professor

Pharmacology, Physiology & Neuroscience

New Jersey Medical School

Rutgers University

Copyright © 2019-2020 Lytica Therapeutics, Inc - All Rights Reserved.